BALTIMORE, MD / ACCESSWIRE / March 31, 2021 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on emerging CBD-infused products provider American Premium Water Corporation (OTC PINK:HIPH), highlighting recent events, new partnerships, upcoming catalysts, and the industry. The report carries a price target. To read this report or previous HIPH reports and updates, along with disclosures and disclaimers, or to download them in their entirety, please visit https://bit.ly/3mfkgxu.
In the Opportunity Research Report, analyst Rob Goldman offers key insights into the business model and prospects for the Company.
Diverse Markets, Diverse Products
Goldman noted, "HIPH offers one of the most diverse product lines in the CBD-infused products industry and is set to sell its offerings through key channel partners in the U.S. and Asia-Pacific (APAC), driving major sales growth. HIPH's success leverages its emphasis on innovation, broad distribution, and enhanced manufacturing capabilities through partnerships. HIPH is no one-trick pony. And the HIPH core business is primed to capture a meaningful share of the $22 Billion market. The Company offers premium beverages, edibles, and topicals that promote wellness and can improve outcomes in certain conditions."
Catalysts and Milestones Ahead Serve as Value Drivers
"Two key partnerships position HIPH for outsized growth in 2021 and beyond. BioHealth Water owns 9.99% of HIPH and serves as a major channel partner in the APAC region. A JV with Cali Bear has opened up a new distribution and fulfillment partnership as well as new product categories," continued Goldman. "Milestone events such as the multi-product Cali Bear introductions in April 2021, along with sales abroad should drive value in these shares. Future uniform product branding, and product launches based on the HIPH proprietary technology platform could broaden the Company's awareness and reach."
Forecasts Suggest Enviable Growth
"Our forecasts suggest sales could reach $2M in 2021 and $9M in 2022, led by new product and market opportunities, including potential CBD sales in APAC. We believe HIPH could generate break-even results in 4Q20 and a 20% net margin next year. Our 6-month price target is based on a typical industry price/sales metric and we should note that HIPH has a history of exceeding our targets," concluded Goldman.
About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.
Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
This press release contains excerpts of our most recently published sponsored company research report on American Premium Water Corporation. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information derived from American Premium Water Corporation ("the Company") authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission http://www.sec.gov.
Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. The report referred to herein does not take into account the investment objectives, financial situation, or particular needs of any particular person and does not provide all information material to an investor's decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency.
To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Since 2020, Goldman Small Cap Research has been compensated by a third party in the amount of $4250 for research reports and press releases.
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
[email protected]
SOURCE: Goldman Small Cap Research